|
MBD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.151600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.769800E-02 |
| Normal-vs-Stage2 |
5.215900E-03 |
| Normal-vs-Stage3 |
9.977800E-03 |
| Normal-vs-Stage4 |
8.300000E-02 |
| Stage1-vs-Stage2 |
6.012300E-02 |
| Stage1-vs-Stage3 |
1.195190E-01 |
| Stage1-vs-Stage4 |
6.014800E-01 |
| Stage2-vs-Stage3 |
4.739400E-01 |
| Stage2-vs-Stage4 |
2.521200E-01 |
| Stage3-vs-Stage4 |
5.283000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.212200E-02 |
| Normal-vs-AfricanAmerican |
4.410400E-01 |
| Normal-vs-Asian |
1.789400E-01 |
| Caucasian-vs-AfricanAmerican |
6.126000E-01 |
| Caucasian-vs-Asian |
9.063400E-01 |
| AfricanAmerican-vs-Asian |
7.081800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.260200E-02 |
| Normal-vs-Female |
3.990300E-02 |
| Male-vs-Female |
7.644800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.683550E-01 |
| Normal-vs-Age(41-60Yrs) |
2.534000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.244300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.460800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.567000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.097800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.406600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.567600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.812600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.074440E-02 |
| Classical-VS-Follicular |
4.20190000000042E-05 |
| Classical-VS-Other |
4.988800E-01 |
| Classical-VS-Normal |
4.126600E-01 |
| Tall-VS-Follicular |
2.455400E-01 |
| Tall-VS-Other |
7.956800E-01 |
| Tall-VS-Normal |
1.126060E-02 |
| Follicular-VS-Other |
4.532600E-01 |
| Follicular-VS-Normal |
1.232390E-04 |
| Other-VS-Normal |
3.172400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.980480E-03 |
| Normal-vs-N1 |
1.053990E-01 |
| N0-vs-N1 |
5.461400E-01 |
|
|
